Anson Funds Management’s Bausch Health BHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-100,000
Closed -$695K 279
2022
Q2
$836K Buy
+100,000
New +$1.4M 0.08% 191
2021
Q3
Sell
-60,000
Closed -$1.76M 310
2021
Q2
$1.76M Buy
60,000
+20,000
+50% +$606K 0.17% 152
2021
Q1
$1.27M Buy
+40,000
New +$1.17M 0.15% 157
2020
Q1
Sell
-30,500
Closed -$913K 65
2019
Q4
$913K Buy
+30,500
New +$793K 1.06% 18
2019
Q3
Sell
-581,569
Closed -$14.7K 35
2019
Q2
$14.7K Buy
+581,569
New +$13.8M 7.1% 4

Other funds holding BHC

Anson Funds Management's BHC Position: Q3 2022 in Review

Anson Funds Management sold out of Bausch Health (BHC) in Q3 2022, closing a stake of 100,000 shares — an estimated $695K sold.

Anson Funds Management first reported a position in BHC in Q2 2019 and held it in 5 quarters. The position peaked at $1.76M in Q2 2021. 283 funds tracked by Wall St. Rank hold BHC as of Q3 2022.

  • Anson Funds Management reported no remaining Bausch Health position as of Q3 2022 after selling out during the quarter.
  • Anson Funds Management sold 100,000 Bausch Health shares in Q3 2022, an estimated $695K.
  • Anson Funds Management first reported a position in Bausch Health in Q2 2019 and held it in 5 quarters.
  • Anson Funds Management's Bausch Health position peaked at $1.76M in Q2 2021.
  • 283 funds tracked by Wall St. Rank held Bausch Health as of Q3 2022.

Based on Anson Funds Management's 13F filing for Q3 2022, filed 15 Nov 2022.